Conduit Pharmaceuticals (FRA:ZK70) FCF Yield % : -220.06 (As of Apr. 02, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Conduit Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Conduit Pharmaceuticals's Trailing 12-Month Free Cash Flow is €-9.02 Mil, and Market Cap is €4.45 Mil. Therefore, Conduit Pharmaceuticals's FCF Yield % for today is -220.06%.

The historical rank and industry rank for Conduit Pharmaceuticals's FCF Yield % or its related term are showing as below:

FRA:ZK70' s FCF Yield % Range Over the Past 10 Years
Min: -220.06 Med: 0 Max: 0
Current: -220.06

FRA:ZK70's FCF Yield % is ranked worse than
91.32% of 1498 companies
in the Biotechnology industry
Industry Median: -15.56 vs FRA:ZK70: -220.06

Conduit Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

Conduit Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Conduit Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conduit Pharmaceuticals FCF Yield % Chart

Conduit Pharmaceuticals Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

FCF Yield %

-122.09

Conduit Pharmaceuticals Quarterly Data
	Dec21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial							-	-	-	-68.22	-191.30

Competitive Comparison of Conduit Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Conduit Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Conduit Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Conduit Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Conduit Pharmaceuticals's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Conduit Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Conduit Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-9.295	/	7.6131
	=	-122.09%

Conduit Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-3.641	*	4	/	7.6131
	=	-191.30%

Conduit Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Conduit Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Conduit Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Conduit Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Conduit Pharmaceuticals Inc (FRA:ZK70) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

CDT:USA

Address

4995 Murphy Canyon Road, Suite 300, San Diego, CA, USA, 92123

Website

https://www.conduitpharma.com

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Conduit Pharmaceuticals Headlines

No Headlines